The latest European impasse over a much-needed stimulus package has finally been overcome, meaning cash-strapped countries will soon get access to a historic level of funding.
"We are looking at hospitalization capacity, and if we don't get the rate under control, you are going to overwhelm your hospitals. We will have to go back to shutdown," he said Monday.
The People's Vaccine Alliance said wealthy nations had bought up enough doses to vaccinate their entire populations nearly three times over by the end of 2021.
People who have a history of "significant" allergic reactions should not receive the Pfizer-BioNTech coronavirus vaccine, the U.K. drug regulator said.
The AstraZeneca-University of Oxford vaccine is the first to have its late-stage trial results independently reviewed and published in a medical journal.
Facebook Chief Executive Mark Zuckerberg threatened to pull investment in the U.K. in a private meeting two years ago with government minister Matt Hancock.
Get complete CNBC business news coverage online. Find the latest business news pertaining to Europe. Sector watch news, headlines; top stories is available on the official CNBC Europe site.